21 January 2018
News and Views
Links and Services
A study in the latest issue of Inflammatory Bowel Diseases investigates whether accelerated infliximab infusions are safe in patients with inflammatory bowel disease.
Infliximab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD).
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors